What does stable disease mean on my Testicular Cancer scan results

Understanding "Stable Disease" on Your Testicular Cancer Scan

Great question—this is an important term to understand when monitoring your cancer treatment response.

What "Stable Disease" Means

Stable disease means that the cancer lesions (tumors or abnormal areas) visible on your scan have not significantly changed in size compared to your previous scan. The disease is neither growing substantially nor shrinking meaningfully.

In practical terms:

• Your tumors are roughly the same size as before
• No new lesions (cancer spots) have appeared
• Existing lesions haven't disappeared

Why This Matters for Testicular Cancer

According to the NCCN Guidelines for Testicular Cancer, response assessment is a critical part of your treatment plan. Stable disease is generally considered a positive finding because it indicates:

1. Your current treatment is working - The cancer isn't progressing (getting worse)
2. Disease control - Your treatment is holding the cancer in check
3. Time for decision-making - It gives your care team time to evaluate next steps without urgent changes

Important Context for Your Situation

The significance of stable disease depends on several factors your oncologist will consider:

• Where you are in treatment - Stable disease early in treatment may lead to continuing your current approach; stable disease after completing treatment is excellent
• Your tumor markers - Your serum tumor markers (AFP, beta-hCG, LDH) are equally important. According to NCCN Guidelines, even with stable imaging, rising tumor markers may indicate disease progression
• Size of residual masses - If you have remaining masses, their size and characteristics matter for determining next steps
• Your overall treatment plan - Whether you're on surveillance, chemotherapy, or post-surgical monitoring

Questions to Ask Your Oncologist

Since stable disease can mean different things depending on your specific situation, here are key questions:

1. "How does this stable disease compare to my baseline scan before treatment started?" - This helps you understand the trajectory
2. "What are my tumor markers showing, and how do they correlate with the stable imaging?" - Markers and imaging should be interpreted together
3. "Does stable disease mean we continue with the current treatment plan, or are there changes ahead?" - Clarify your next steps
4. "How often will we repeat imaging to monitor for changes?" - According to NCCN Guidelines, follow-up frequency depends on your stage and treatment type
5. "Are there any concerning features on the scan I should know about, even though it's stable?" - Some stable lesions may have features requiring closer monitoring

Follow-Up Monitoring

According to NCCN Guidelines for Testicular Cancer, your follow-up schedule will depend on your specific stage and treatment:

• Stage I patients typically have imaging every 4-6 months initially, then annually
• Stage II-III patients after chemotherapy have more frequent monitoring (every 4-6 months initially)
• Your doctor may adjust frequency based on your individual risk factors

The key is that stable disease buys you time—it's not a "cure," but it's a positive sign that your treatment strategy is working.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.